Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Neurology Physician in Long Beach, CA
NPI: 1184678583Primary Practice Location
Southland Neurologic Institute a Medical Corporation
3747 Worsham Ave, Long Beach, CA
Primary Employer
Southland Neurologic Institute a Medical Corporation
myneurologists.com
HQ Phone
Get M.D. Omid's Phone Numberphone_androidMobile
Get M.D. Omid's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1996 - 2027
American Board of Psychiatry and Neurology
Neurology
Other
Medical School
Until 1992
Los Angeles County-Harbor-UCLA Medical Center
Residency • Neurology
1995 - 1998
Kirk Kerkorian School of Medicine at UNLV
unlv.edu
Residency • Internal Medicine
1994 - 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 346 | 949 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 279 | 500 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 266 | 277 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 195 | 430 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 140 | 205 |
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinica...
Authors: Joseph Jankovic, Ira J. Goodman, Beth Safirstein, Tonya K. Marmon, Dale Schenk
Authors: Robert Lufkin, Konrad Kirlew, David Gozal
Journal: J Clin Invest
Identification of human brain regions underlying responses to resistive inspiratory loading with functional magnetic resonance imaging.
Authors: Robert Lufkin, Konrad Kirlew, David Gozal
Publication Date: 1995-07
Lead Sponsor: Acorda Therapeutics
Intervention / Treatment: DRUG: Sinemet, DRUG: CVT-301
Lead Sponsor: Biojiva LLC
Intervention / Treatment: DRUG: High dose cohort, DRUG: Low dose cohort
Lead Sponsor: Prothena Biosciences Limited
Collaborators: Hoffmann-La Roche
Intervention / Treatment: OTHER: Placebo, DRUG: PRX002
